Terms: = Lung cancer AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5 AND Treatment
7 results:
1. Comprehensive characterization of B7 family members in NSCLC and identification of its regulatory network.
Xiao M; Pang C; Xiang S; Zhao Y; Wu X; Li M; Du F; Chen Y; Wang F; Wen Q; Xiao Z; Yang Z; Shen J
Sci Rep; 2023 Mar; 13(1):4311. PubMed ID: 36922519
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of nivolumab plus ipilimumab versus platinum-doublet chemotherapy for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Berling M; Chaudhary MA; Yuan Y; Varol N; Dale P; Testa E; Klint J; Lee A; Lubinga SJ; Penrod JR
J Med Econ; 2022; 25(1):703-711. PubMed ID: 35659172
[TBL] [Abstract] [Full Text] [Related]
3. Cost-effectiveness analysis of nivolumab plus ipilimumab plus two cycles of platinum-doublet chemotherapy versus platinum-doublet chemotherapy alone for first-line treatment of stage IV or recurrent non-small cell lung cancer in the United States.
Polyzoi M; Sandhu H; Maervoet J; Yuan Y; Chaudhary MA; Varol N; Lee A; Dale P; Jones C; Lubinga SJ; Penrod JR
J Med Econ; 2022; 25(1):660-668. PubMed ID: 35658806
[TBL] [Abstract] [Full Text] [Related]
4. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
[TBL] [Abstract] [Full Text] [Related]
5. EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma.
Dong Z; Zhang L; Xu W; Zhang G
Mol Med Rep; 2018 Oct; 18(4):3769-3779. PubMed ID: 30106102
[TBL] [Abstract] [Full Text] [Related]
6. Expression pattern of parkin isoforms in lung adenocarcinomas.
D'Amico AG; Maugeri G; Magro G; Salvatorelli L; Drago F; D'Agata V
Tumour Biol; 2015 Jul; 36(7):5133-41. PubMed ID: 25656612
[TBL] [Abstract] [Full Text] [Related]
7. Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.
Dubray B; Henry-Amar M; Meerwaldt JH; Noordijk EM; Dixon DO; Cosset JM; Thames HD
Radiother Oncol; 1995 Sep; 36(3):211-7. PubMed ID: 8532908
[TBL] [Abstract] [Full Text] [Related]
